Evaluation of the ocular safety and efficacy of a drug delivery system in open-angle glaucoma or ocular hypertension.
Inclusion Criteria:
Exclusion Criteria:
Miami, Florida, United States
Philadelphia, Pennsylvania, United States
Mt. Pleasant, South Carolina, United States
Rapid City, South Dakota, United States
Maryville, Tennessee, United States